United States · FDA National Drug Code directory
Cetirizine hydrochloride - HIVES
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70010-293_569120e7-e21e-c7a2-e063-6394a90a2346
- Product NDC
- 70010-293
- Form
- TABLET, COATED
- Composition / generic term
- Cetirizine hydrochloride
- Labeler
- Granules Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250902
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, COATED in 1 BOTTLE (70010-293-10) · 70010-293-10
- 14 TABLET, COATED in 1 BOTTLE (70010-293-14) · 70010-293-14
- 13 BLISTER PACK in 1 CARTON (70010-293-79) / 10 TABLET, COATED in 1 BLISTER PACK (70010-293-56) · 70010-293-79
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →